anti-RLIP76 antibodies (University of Texas)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameanti-RLIP76 antibodies (University of Texas)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Texas System
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Texas System
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A